Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Biologics
•
Pulmonology
•
Bronchiectasis
Do you use biologic agents in patients with eosinophilic bronchiectasis?
If so, what is your threshold to start?
Related Questions
Is there a role for biologics to improve lung function in patients who have severe asthma with daily symptoms and reduced lung function but do not experience frequent exacerbations?
Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?
How would you manage a patient with bronchiectasis who has persistently positive sputum with Pseudomonas and chronic sputum production but is otherwise asymptomatic?
What is your approach to the work up and evaluation of loss of asthma control while on a biologic such as dupilumab?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
How do you manage patients with central sleep apnea due to heart failure with reduced ejection fraction?
Is methacholine challenge on its way out?
